Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit ...

The Lehigh Valley plant will be Indianapolis-based Lilly’s first manufacturing facility in Pennsylvania. Construction is ...

How the Lehigh Valley beat hundreds of competitors to land Eli Lilly’s $3.5 billion pharmaceutical plant ...

What Happened? Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 7.4% in the morning session after the ...

On Friday, Eli Lilly unveiled its plans for a $3.5 billion pharmaceutical plant to be built on Main Street in Upper Macungie ...

By Leah Douglas WASHINGTON, Jan 30 (Reuters) - Eli Lilly announced on Friday that it will build a pharmaceutical ...

Historical evidence indicates that abrupt market fluctuations can affect any corporation, regardless of its perceived dominance.

Pharmaceutical giant Eli Lilly & Co. (NYSE: LLY) will open a $3.5 billion manufacturing facility in the Lehigh Valley community of Upper Macungie. The development will span about 925,000 square feet ...

A case targeting alleged fraud around the safety risk of a blockbuster diabetes drug is leveraging the RICO pathway and could have a ripple effect in pharma.

Eli Lilly has outperformed the broader market over the past year, and analysts remain highly bullish about the stock’s ...

Find latest healthcare news from every corner of the globe at Reuters.com, your online source for breaking international news ...

Eli Lilly CEO David Ricks, left, and Pennsylvania Gov. Josh Shapiro at a Lehigh County event on Jan. 30, 2026. Eli Lilly will ...